Feedback Share Discussion Threads

[yump] 26/8/2021 14:19

That’s why the CE mark is a red herring. Its not a benefit.

The clinical imaging and ability to annotate is. Hopefully that is what’s being presented to sell Bleepa.

[lr2] 26/8/2021 09:10

Thanks Ged. That's more like it.

[ged5] 26/8/2021 09:00

I read this and I still wonder why there haven't been more contracts. Not tweeted to #FDBK, FBKMED, Javed or every Trusts CIO.



New Service area on the website including this:-.

[victor2] 25/8/2021 13:20

It needs to be something better than that!

[lr2] 25/8/2021 13:08

They have the Fairfield General news to release. I have to assume they are now holding that back for after a possible placing.

[victor2] 25/8/2021 12:51

Good luck to pamure, they will need it.Feel sorry for
stanford having introduced the company
to a good group of institutions raising over 5mill in the
process only to be dumped, as davydoos post points out you cant expect
them to stump up again after what has happened since.
the only consolation could be that they have some positive news to release
with the fund raising.

[ydderf] 25/8/2021 10:27

Dilution and market cap. TO joined the board February 2019. Since then there have been two placings. One for £2m in August 2019 and one for £5.27m in July 2020. Total 7.27m. Any shareholder in July 2019 would now be owning a very much smaller part of that cake, less than half of what they had before, whatever it is or will be worth, than now.

A further curiosity, strange but true, is that even the current market cap is now less than the £7m cash raised in those placings

With near zero sales and no verifiably commercial contracts announced and an apparent need for reloading the cash bonfire, this investment should be characterised as an 'anti-investment" in view of the carnage wreaked upon the pbs (poor bloody shareholders)

[mrscocker] 25/8/2021 09:33

Yump, did you really just post that as well? So says the man who sets up a new thread just to troll a share he has no interest in. HYPOCRITE you are still trolling DVRG because you lost a shedload on VENN and SKIN years ago. FACT and that's the real definition of SAD

[mrscocker] 25/8/2021 09:28

Whinge whine whinge

[yump] 25/8/2021 09:27

Its also quite suspicious imo that the share price has halved before the broker change and the inevitable ? placing. Seen that a few times.

[mrscocker] 25/8/2021 09:26

Yump, did you really just post that here?

One word to describe you: HYPOCRITE and you know exactly why.

[davydoo] 25/8/2021 09:17

I think that’s a good point about dilution generally, people are totally focussed on share price and not share of market cap. You should always work it out even if it’s 0.0001%

Not surprised by the broker move, how can you go back to the same pool of clients at half the price?

[ydderf] 25/8/2021 09:07

Impotent shareholders who have locked themselves in because they believe "it is too late to sell" or it is "one for the bottom drawer" some here (you know who you are) do not seem to understand the concept of dilution and market cap. Hopefully nobody has invested life changing sums here. Meanwhile the smartest move TO has made to date is not to buy the shares all the way down from when he was appointed until now

[orange1] 25/8/2021 08:09

But on the bright side, this appointment heralds a “step change in our growth plans”. Lol!

[1bond] 25/8/2021 07:45

Panmure are only interested in a large placing fee

[ydderf] 25/8/2021 07:40

My guess is that a relatively large refinancing/reconstruction/relaunch is a possibility, after all Feedback has been able to raise millions in placing over the last two or three years and presumably could continue to do so. Panmure do not come cheap, though to be fair, its not as if FBDK has to earn this (OPM) money, anymore than it has too earn any other expense - it comes out of the cash bonfire. Hats off to TO though he must have been a very credible presenter to get Panmure hooked. Sadly it is looking as if present shareholders will be diluted out of sight at some point in the near future...

[ptolemy] 25/8/2021 07:37

Or Oakley blamed Allenby for his own failings....

[1bond] 25/8/2021 07:08

Must be a placing coming. We know cash is tight

[ducatiman] 25/8/2021 07:07

Change of adviser, now I wonder why? 🤔.
“ broad institutional reach, will help us” Ah!

[ydderf] 24/8/2021 11:07

That pesky seller is at it again I see. Well at least it can't be TO, because he doesn't have any shares to sell!

[lr2] 23/8/2021 11:52

Morning Digger, doing OK thanks. All very quiet here at present. Someone modified the following Bleepa web page on the 18th. Think they added this line, "Bleepa has also created a source of data that can be interrogated to support links between patient treatment and outcomes." That's about it for now.